NAVB | Navidea Biopharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)

*Sign In to persist settings

Financial Year End	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31
Revenue	65.65K	531.51K	915.01K	26.62K	322.52K	1.81M	21.97M	13.25M	6.27M	1.13M	78.74K	597.73K	10.70M	9.52M	7.89M	7.12M	6.05M	5.92M	5.95M	6.51M	4.92M	7.58M	9.71M	9.45M	5.83M	5.13M	1.17M	1.00M	900.00K	100.00K
Cost of Revenue	184.95K	198.83K	1.05K	6.67K	96.64K	3.65K	2.30M	1.75M	1.59M	332.81K	N/A	N/A	3.21M	3.13M	3.01M	3.18M	2.63M	2.38M	2.34M	3.12M	2.35M	4.39M	4.63M	3.95M	1.40M	1.58M	676.77K	500.00K	100.00K	5.90M
Gross Profit	-119.30K	332.68K	913.97K	19.95K	225.88K	1.81M	19.67M	11.49M	4.69M	797.82K	78.74K	597.73K	7.49M	6.38M	4.88M	3.94M	3.42M	3.54M	3.61M	3.38M	2.57M	3.20M	5.08M	5.49M	4.43M	3.55M	494.41K	500.00K	800.00K	-5.80M
Operating Expenses	13.93M	12.59M	11.63M	10.98M	11.07M	15.68M	21.90M	30.05M	32.32M	39.24M	28.07M	24.70M	13.80M	8.21M	7.92M	41.23M	6.88M	7.19M	5.61M	5.00M	5.59M	2.67M	3.43M	10.07M	32.90M	30.82M	23.84M	11.90M	12.60M	2.40M
Selling, General & Admin	7.96M	7.45M	6.69M	6.28M	7.70M	11.17M	13.01M	17.26M	15.54M	15.53M	11.18M	9.55M	4.58M	3.24M	3.41M	2.84M	3.08M	3.16M	3.15M	3.10M	3.27M	2.32M	2.96M	8.21M	10.55M	11.16M	7.75M	3.60M	12.00M	2.30M
Research & Development	5.97M	5.14M	4.93M	5.34M	4.22M	4.51M	8.88M	12.79M	16.78M	23.71M	16.89M	15.15M	9.22M	4.97M	4.51M	2.87M	3.80M	4.03M	2.45M	1.89M	2.32M	344.68K	472.73K	1.31M	12.96M	19.66M	16.08M	7.80M	N/A	N/A
Other Operating Expenses	N/A	-14.12K	-21.86K	-631.21K	1.15K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	35.53M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	552.96K	9.38M	N/A	N/A	500.00K	600.00K	100.00K
Operating Income	-14.05M	-12.06M	-10.71M	-10.96M	-10.85M	-13.88M	-2.22M	-18.55M	-27.63M	-38.44M	-27.99M	-24.10M	-6.31M	-1.82M	-3.04M	-1.76M	-3.46M	-3.64M	-2.00M	-1.61M	-2.99M	-352.20K	1.29M	-4.58M	-28.47M	-27.26M	-23.34M	-11.40M	-11.80M	-8.20M
Other Expenses / Income	-1.13M	345.52K	-10.51K	17.68K	-5.32M	-3.91M	2.77M	-10.32M	-13.14M	-4.26M	-1.17M	-943.16K	-37.20M	1.82M	-2.12M	-3.33M	-1.28M	-1.28M	-1.24M	-10.38K	28.48K	369.77K	371.83K	386.58K	26.50K	1.92M	276.87K	900.00K	900.00K	300.00K
Before Tax Income	-15.18M	-11.71M	-10.72M	-10.94M	-16.17M	-17.79M	-14.31M	-28.76M	-35.73M	-42.70M	-29.16M	-25.05M	-49.96B	-39.61B	-5.17B	-5.09B	-4.74B	-4.93B	-3.24M	-1.62M	-2.96M	17.57K	1.66M	-4.19M	-28.44M	-25.34M	-23.07M	-10.50M	-10.90M	-7.90M
Income Tax Expenses	N/A	16.04K	-81.74K	707.00	2.75K	-4.06M	-648.00K	-436.05K	2.68M	2.37M	43.33M	-7.88M	43.65M	37.45M	2.12M	-32.20M	1.28M	1.28M	1.54M	187.87K	-726.00	2.62K	-194.07K	-407.40K	-435.54K	-4.02M	-2.37M	400.00K	200.00K	N/A
Net Income	-15.18M	-11.73M	-10.64M	-10.95M	-16.13M	74.95M	-14.31M	-27.56M	-35.73M	-42.70M	-29.16M	5.61M	-49.96M	-39.61M	-5.17M	-5.09M	-4.74M	-4.93M	-3.54M	-1.80M	-2.96M	14.95K	1.84M	-4.17M	-28.03M	-23.25M	-20.97M	-10.80M	-10.80M	-8.00M
Interest Expenses	1.10M	6.36K	N/A	25.29K	30.80K	168.97K	4.87K	1.27M	3.71M	2.78M	1.17M	13.33K	554.99K	1.53M	1.74M	2.28M	1.50M	1.35M	334.20K	186.91K	31.95K	11.10K	24.88K	N/A	189.78K	N/A	83.44K	200.00K	100.00K	N/A
Basic Shares Outstanding	29.34M	29.34M	23.90M	14.39M	8.53M	8.08M	7.77M	7.56M	7.44M	6.09M	4.95M	4.53M	4.04M	3.69M	3.43M	3.15M	2.93M	2.92M	2.84M	2.02M	1.80M	1.29M	1.29M	1.15M	1.14M	1.14M	990.57K	694.44K	457.63K	353.98K
Diluted Shares Outstanding	30.90M	29.34M	23.90M	14.39M	8.53M	8.30M	7.77M	7.56M	7.44M	6.09M	4.95M	4.53M	4.04M	3.69M	3.43M	3.15M	2.93M	2.92M	2.84M	2.02M	1.80M	1.30M	1.32M	1.15M	1.14M	1.14M	990.57K	694.44K	457.63K	353.98K
EBITDA	-13.88M	-11.51M	-10.64M	-10.82M	-10.85M	-13.14M	-6.87M	-21.31M	-31.52M	-38.03M	-27.79M	-24.86M	-49.10M	-35.85M	-2.48M	-2.40M	-2.83M	-2.97M	-1.14M	-853.34K	-2.22M	955.59K	1.67M	-4.03M	-27.20M	-26.37M	-22.97M	-11.80M	-12.10M	-8.40M
EBITDA Margin	-21,134.32%	-2,164.89%	-1,162.91%	-40,641.69%	-3,363.29%	-726.04%	-31.28%	-160.86%	-502.33%	-3,363.98%	-35,295.09%	-4,158.69%	-458.85%	-376.64%	-31.43%	-33.68%	-46.82%	-50.25%	-19.20%	-13.11%	-45.20%	12.60%	17.16%	-42.65%	-466.26%	-514.21%	-1,960.93%	-1,180.00%	-1,344.44%	-8,400.00%
EBIT	-14.08M	-11.71M	-10.72M	-10.92M	-16.09M	71.05M	-14.95M	-26.73M	-29.34M	-37.55M	15.34M	-2.25M	-5.76M	-625.61K	-1.30M	-35.01M	-1.96M	-2.29M	-1.66M	-1.42M	-2.93M	28.67K	1.67M	-4.58M	-28.28M	-27.26M	-23.26M	-10.20M	-10.50M	-8.00M
EBIT Margin	-21,444.63%	-2,202.87%	-1,171.75%	-41,023.19%	-4,989.72%	3,924.61%	-68.06%	-201.74%	-467.55%	-3,320.81%	19,485.04%	-377.06%	-53.79%	-6.57%	-16.45%	-491.36%	-32.46%	-38.75%	-27.97%	-21.88%	-59.59%	0.38%	17.21%	-48.50%	-484.83%	-531.69%	-1,985.89%	-1,020.00%	-1,166.67%	-8,000.00%
Financial Year End	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31